+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Psoriatic Arthritis Drug"

Psoriatic Arthritis Treatment - Global Strategic Business Report - Product Thumbnail Image

Psoriatic Arthritis Treatment - Global Strategic Business Report

  • Report
  • September 2026
  • 452 Pages
  • Global
From
Psoriatic Arthritis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Psoriatic Arthritis Therapeutics - Global Strategic Business Report

  • Report
  • September 2026
  • 276 Pages
  • Global
From
Psoriatic Arthritis Treatment Market Report 2026 - Product Thumbnail Image

Psoriatic Arthritis Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Rheumatology Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Rheumatology Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 193 Pages
  • Global
From
Biosimilar Monoclonal Antibodies Market - Global Forecast 2026-2032 - Product Thumbnail Image

Biosimilar Monoclonal Antibodies Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 184 Pages
  • Global
From
Autoimmune Disease Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Autoimmune Disease Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 195 Pages
  • Global
From
TNF Inhibitors Market - Global Forecast 2026-2032 - Product Thumbnail Image

TNF Inhibitors Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 180 Pages
  • Global
From
Psoriatic Arthritis - Global Clinical Trials Review, 2026 - Product Thumbnail Image

Psoriatic Arthritis - Global Clinical Trials Review, 2026

  • Clinical Trials
  • February 2026
  • 760 Pages
  • Global
From
From
Psoriatic Arthritis (PSA) Treatment Market - Product Thumbnail Image

Psoriatic Arthritis (PSA) Treatment Market

  • Report
  • October 2025
  • 96 Pages
  • Global
From
From
Loading Indicator

Psoriatic Arthritis Drug is a type of drug used to treat psoriatic arthritis, a type of immune disorder. It is a chronic, inflammatory condition that affects the joints and skin. Psoriatic Arthritis Drug works by targeting the underlying cause of the disease, which is an overactive immune system. It helps to reduce inflammation and pain, and can also slow down the progression of the disease. Commonly used Psoriatic Arthritis Drugs include biologics, non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, and disease-modifying antirheumatic drugs (DMARDs). The Psoriatic Arthritis Drug market is a rapidly growing segment of the Immune Disorders Drugs market. It is driven by the increasing prevalence of psoriatic arthritis, as well as the development of new and more effective treatments. The market is expected to continue to grow in the coming years, as more treatments become available and the demand for them increases. Some of the major companies in the Psoriatic Arthritis Drug market include AbbVie, Amgen, Bristol-Myers Squibb, Eli Lilly, Janssen, Merck, Novartis, Pfizer, and Roche. Show Less Read more